Ketogenic diet may be good for some, risky for others – study aims to find out who
NCT ID NCT07675603
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study investigates why a low-carb, high-fat (ketogenic) diet raises 'bad' cholesterol in some people but not others, and how it affects blood sugar. Twenty healthy adults will follow both a ketogenic diet and a standard diet for 24 hours, repeating each three times. The goal is to see if individual differences in response are real and consistent, which could one day help doctors give personalized diet advice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-carbohydrate (ketogenic) diet
- What this could lead to
- If successful, this could help identify who might benefit from a ketogenic diet and who should avoid it due to increased heart disease risk.
- What could go wrong
- This is a small, early-stage study with only 20 healthy participants, so results may not apply to everyone. The diet may raise LDL cholesterol in some people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Bath
RECRUITINGBath, Bath and North East Somerset, BA2 7AY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test